Inventor · disambiguated record
Wei Meng
Also filed as: MENG WEI
34 granted patents·3 pending applications·1,034 citations·filing 2000–2024
97Inventor score
Top patents by PatentIndex Score
37 records- 0198US6515117B2C-aryl glucoside SGLT2 inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Feb 4, 2003·372 cites·17 claims
- 0298US6414126B1C-aryl glucoside SGLT2 inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Jul 2, 2002·380 cites·30 claims
- 0397US6936590B2C-aryl glucoside SGLT2 inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Aug 30, 2005·133 cites·9 claims
- 0496US7589193B2C-aryl glucoside SGLT2 inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Sep 15, 2009·67 cites·15 claims
- 0593US8791091B2Aryl dihydropyridinone and piperidinone MGAT2 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Jul 29, 2014·18 cites·103 claims
- 0691US9663466B2Aryl dihydropyridinones and piperidinone MGAT2 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted May 30, 2017·8 cites·7 claims
- 0791US7365061B22-Amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Apr 29, 2008·12 cites·7 claims
- 0890US9901572B2Aryl dihydropyridinones and piperidinone MGAT2 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Feb 27, 2018·6 cites·21 claims
- 0990US9187424B1Aryl dihydropyridinones and piperidinone MGAT2 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Nov 17, 2015·10 cites·18 claims
- 1089US10695328B2Aryl dihydropyridinones and piperidinone MGAT2 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jun 30, 2020·2 cites·40 claims
- 1188US9701672B2Dihydropyridinone MGAT2 inhibitors for use in the treatment of metabolic disordersBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jul 11, 2017·8 cites·23 claims
- 1286US10369140B2Aryl dihydropyridinones and piperidinone MGAT2 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Aug 6, 2019·3 cites·17 claims
- 1380US10106528B26-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonistsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Oct 23, 2018·3 cites·58 claims
- 1480US7910747B2Phosphonate and phosphinate pyrazolylamide glucokinase activatorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Mar 22, 2011·3 cites·3 claims
- 1579US7223786B22-aminonaphthalene derivatives and related glycogen phosphorylase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted May 29, 2007·2 cites·7 claims
- 1678US9856244B2Dihydropyridinone MGAT2 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jan 2, 2018·2 cites·20 claims
- 1775US11390616B2Apelin receptor agonists and methods of useBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jul 19, 2022·1 cites·4 claims
- 1875US2021161869A1Aryl dihydropyridinones and piperidinone mgat2 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 1972US10966967B2Aryl dihydropyridinones and piperidinone MGAT2 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Apr 6, 2021·0 cites·20 claims
- 2070US12168655B2Apelin receptor agonists and methods of useBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Dec 17, 2024·0 cites·14 claims
- 2170US7635699B2Azolopyrimidine-based inhibitors of dipeptidyl peptidase IV and methodsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Dec 22, 2009·1 cites·3 claims
- 2269US8592396B2Glucokinase activators and methods of using sameMENG WEI·Filed 2011·Granted Nov 26, 2013·2 cites·12 claims
- 2367US2025145590A1Ubiquitin specific processing protease 1 (usp1) compoundsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 2460US7342127B2Substituted anilide ligands for the thyroid receptorBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Mar 11, 2008·1 cites·23 claims
- 2551US10590113B26-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonistsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Mar 17, 2020·0 cites·10 claims
- 2651US8614332B2Substituted pyrazolylamides useful as glucokinase activatorsRYONO DENIS E·Filed 2012·Granted Dec 24, 2013·0 cites·18 claims
- 2750US10604541B2Glucokinase activators and methods of using sameBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Mar 31, 2020·0 cites·19 claims
- 2848US8153677B2Substituted pyrazolylamide compounds useful as glucokinase activatorsRYONO DENIS E·Filed 2011·Granted Apr 10, 2012·0 cites·17 claims
- 2947US7589088B2Pyrimidine-based inhibitors of dipeptidyl peptidase IV and methodsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Sep 15, 2009·0 cites·15 claims
- 3045US7226942B22-amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jun 5, 2007·0 cites·7 claims
- 3145US2004176425A1Cycloalkyl containing anilide ligands for the thyroid receptorFiled 2004·Application pending·0 cites
- 3242US10730863B2Bridged bicyclic compounds as farnesoid X receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Aug 4, 2020·0 cites·27 claims
- 3341US10889565B24-hydroxy-3-sulfonylpyridin-2(1H)-ones as APJ receptor agonistsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jan 12, 2021·0 cites·10 claims
- 3441US10597370B22-(benzothiazol-2-yl)-2-cyano-acetamide derivatives and their use as endothelial lipase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Mar 24, 2020·0 cites·17 claims
- 3540US10508104B26-hydroxy-5-(phenyl/heteroarylsulfonyl)pyrimidin-4(1H)-one as APJ agonistsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Dec 17, 2019·0 cites·17 claims
- 3640US10392347B22,4-dihydroxy-nicotinamides as APJ agonistsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Aug 27, 2019·0 cites·10 claims
- 3739US10669261B2Heteroarylhydroxypyrimidinones as agonists of the APJ receptorBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 2, 2020·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Wei Meng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →